Table 4.
Comparison of initial and follow-up clinical outcomes.
Results | All | Atlas | Leo Baby | P value |
---|---|---|---|---|
Clinical outcome at discharge, n (%) | ||||
Good clinical outcome (mRS 0–2) | 48/56 (85.7) | 26/32 (81.3) | 22/24 (91.7) | 0.444 |
Poor clinical outcome (mRS 3–6) | 8/56 (14.3) | 6/32 (18.8) | 2/24 (8.3) | 0.444 |
All-cause mortality at discharge | 3/56 (5.4) | 3/32 (9.4) | 2/24(0) | 0.252 |
Clinical outcome at follow-up | ||||
Follow-up period | 13.5±6.7 | 8.9±2.5 | 18.9±6.0 | <0.0001 |
Good clinical outcome (mRS 0–2), n (%) | 49/56 (87.5) | 27/32 (84.4) | 22/24 (91.7) | 0.686 |
Poor clinical outcome (mRS 3–6), n (%) | 7/56 (12.5) | 5/32 (15.6) | 2/24 (8.3) | 0.686 |
All-cause mortality at follow-up, n (%) | 6/56 (10.7) | 4/32 (12.5) | 2/24(8.3) | 0.691 |
mRS, modified Rankin Scale.